Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novo-Nordisk A/S

62.62
+0.54000.87%
Post-market: 62.630.0099+0.02%17:31 EDT
Volume:6.27M
Turnover:392.18M
Market Cap:277.97B
PE:19.93
High:63.25
Open:62.19
Low:61.97
Close:62.08
Loading ...

Prediction: These Could Be the Best-Performing Value Stocks Through 2030

Motley Fool
·
24 Feb

Novo Nordisk A/S (NVO): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts

Insider Monkey
·
23 Feb

Why Novo Nordisk A/S (NVO) Surged On Friday?

Insider Monkey
·
22 Feb

Market Today: UnitedHealth Faces DOJ Probe, Novo Nordisk Resolves Drug Shortage

GuruFocus
·
22 Feb

FDA says Ozempic and Wegovy shortage is ending. That's bad news for this wellness stock.

Dow Jones
·
22 Feb

Novo Nordisk Shares Rise After FDA Clears Shortage of Anti-Obesity Drugs -- WSJ

Dow Jones
·
22 Feb

Hims & Hers Stock Plummets. The Wegovy Shortage Is Over. -- Barrons.com

Dow Jones
·
22 Feb

Pfizer Discontinues Hemophilia Gene Therapy Beqvez As Interest Wanes

Benzinga
·
22 Feb

Why Is HIMS Stock Dropping Today?

TIPRANKS
·
22 Feb

Analysts explain why Hims & Hers stock is crashing today

Investing.com
·
22 Feb

Nordic Shares Gain; Novo Nordisk Series B Climbs Highest

Dow Jones
·
22 Feb

Novo Nordisk A/S Stock Rises Friday, Outperforms Market

Dow Jones
·
22 Feb

Top Midday Stories: UnitedHealth Under DOJ Investigation Over Medicare Billing Practices; Novo Nordisk Resolves Ozempic Shortage

MT Newswires Live
·
22 Feb

“Novo Nordisk Is Up, But the Market Is Not Rational!” – Jim Cramer on Novo Nordisk A/S (NVO)

Insider Monkey
·
22 Feb

U.S. FDA Declares Shortage of Novo Nordisk's Wegovy, Ozempic Over -- Update

Dow Jones
·
22 Feb

Novo Nordisk Takes Step Toward Normalized U.S. Obesity Market -- Market Talk

Dow Jones
·
22 Feb

Hims Stock Crashes After FDA Resolves Weight-Loss Drugs Shortage

Blockhead
·
22 Feb

Hims & Hers Health Shares Tumble After Novo Nordisk Says Wegovy, Ozempic Shortage is Over

Dow Jones
·
22 Feb

Leerink sees potential for ‘reset’ in Hims & Hers with Ozempic shortage ended

TIPRANKS
·
21 Feb

U.S. Drug Regulator Declares Wegovy, Ozempic Shortage Over, Novo Nordisk Says

Dow Jones
·
21 Feb